课题基金 / 基金详情

Reguratory mechanisms in growth and differentiation of human embryonal carcinoma --- a model of human embryo.

Reguratory mechanisms in growth and differentiation of human embryonal carcinoma --- a model of human embryo.
人胚胎癌生长和分化的调控机制——人胚胎模型。
批准号:
03670770
负责人:
SEKIYA Souei
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1992

项目摘要

项目成果

SEKIYA Souei的其他基金

相似基金

相关文献

中文摘要
翻译
10 μ M HMBA可诱导人胚胎癌细胞株NEC-14发生形态学分化<-2>。为了阐明分化谱系,我们研究了细胞表面抗原,凝集素结合位点,中间丝,细胞外基质和分泌蛋白的变化。抗原表达的最明显变化是主要组织相容性抗原HLA-A、B、C的诱导,以及阶段特异性胚胎抗原从SSEA-1^-/SSEA-3^+到SSEA-1^+/SSEA-3^-的变化。波形蛋白(Vimentin)是一种间充质中间纤维,只有在分化后才能检测到,提示HMBA诱导NEC-14细胞分化为胚胎中胚层的间充质成分。2、检测了NEC-14细胞中几种细胞癌基因的表达。N-myc的表达水平在未分化的细胞中最高,但在HMBA处理后不久短暂下降至原始水平的1/10以下。建立了几个组成型表达外源N-myc基因的NEC-14转化子。与亲本NEC-14细胞相比,这些转化子表现出不同的特性,例如更高的平板接种效率、更短的群体倍增时间和更高的致瘤潜能,表明额外的N-myc基因赋予细胞更高的转化状态。3、从人畸胎瘤细胞系PA-1中,我们建立了克隆系PA-1/NR,当作为体外多细胞球状体培养时,其稳定地产生神经细胞的独特细胞排列。玫瑰花结的形成伴随着细胞外基质成分,包括层粘连蛋白和IV型胶原蛋白的显著极化和重叠沉积。
英文摘要
1, A pluripotent human embryonal carcinoma cell line (NEC-14) could be induced to morphologically differentiate by treatment with 10^<-2> M HMBA in vitro. To clarify the differentiating lineage, we examined the changes in cell surface antigens, lectin-binding sites, intermediate filaments, and extracellular matrix and secreted proteins. The most distinct changes in antigen expression were the induction of major histocompatibility antigens, HLA-A,B,C, and the changes of stage-specific embryonic antigens, from SSEA-1^-/SSEA-3^+ to SSEA-1^+/SSEA-3^-. Vimentin, a well-known mesenchymal intermediate filament, could be detected only after the differentiation, suggesting that NEC-14 cells were differentiated by HMBA treatment into mesenchymal elements of embryonal mesoderm.2, The expression of several cellular oncogenes in the NEC-14 cells was also examined. The level of N-myc expression was the highest in undifferentiated cells, but decreased transiently shortly after the HMBA treatment to less than 1/10 of the original level. Several NEC-14 transformants constitutively expressing exogenous N-myc gene were established. Compared with the parental NEC-14 cells, these transformants show d quite different properties, for example, higher plating efficiency, shorter population doubling times, and increased tumorigenic potentials, indicating that additional N-myc genes confer the more transformed state on the cells.3, From the human teratocarcinoma cell line PA-1, we established a clonal line, PA-1/NR, that stably produced a distinct cellular arrangement of neural rosettes when cultured as in vitro multicellular spheroids. The rosette formation accompanied a strikingly polarized and overlapped deposition of extracellular matrix components including laminin and type IV collagen.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
S.Sekiya,M.Kawata,et al.: "Induction of human embryonal carcinoma cell differentiation using N,N'ーhexamethylene bisacetamide in vitro" Gynecol.Oncol.36. 69-78 (1990)
S.Sekiya、M.Kawata 等人:“体外使用 N,N-六亚甲基双乙酰胺诱导人胚胎癌细胞分化”Gynecol.Oncol.36 (1990)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
木村 博昭,関谷 宗英,他: "多分化能を有するヒトEmbryonal Carcinoma(EC)細胞のHexamethylene Bisacetamide(HMBA)による分化誘導前後における形質発現の変化。" 日産婦誌. 43. 1477-1483 (1991)
Hiroaki Kimura、Munehide Sekiya 等人:“六亚甲基双乙酰胺 (HMBA) 诱导多能人胚胎癌 (EC) 细胞分化前后性状表达的变化。Nissan Gynecology”。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Eiji Hara,et al: "Protein phosphorylation required for formation of E2F complexes regulates N-myc transcription duging differentiation of human embryonal carcinoma cells." Oncogene.
Eiji Hara 等人:“E2F 复合物形成所需的蛋白质磷酸化调节 N-myc 转录,从而促进人胚胎癌细胞的分化。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
18
    Identification of A Group of Genes Associated with Oncogenesis of Ovarian Cancers
    • 批准号:
      08457435
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $5.18万
    • 财政年份:
      1996
    • 负责人:
      SEKIYA Souei
    • 依托单位:
    Development of an early detection method and specific immunotherapy of ovarian cancers
    • 批准号:
      05454439
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $2.82万
    • 财政年份:
      1993
    • 负责人:
      SEKIYA Souei
    • 依托单位:
    Basic study on the differentiation induction of human germ cell tumors and its clinical application
    • 批准号:
      01570919
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1989
    • 负责人:
      SEKIYA Souei
    • 依托单位:
    Induction of differentiation on the differentiation of human embryonal carcinoma
    • 批准号:
      62570743
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.22万
    • 财政年份:
      1987
    • 负责人:
      SEKIYA Souei
    • 依托单位:
    国内基金
    海外基金
    Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
    • 批准号:
      82370979
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      张善勇
    • 依托单位:
    BRD4通过结合TEAD1调控β细胞增殖分化的机制研究
    • 批准号:
      82370801
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      李峰
    • 依托单位:
    生理/病理应激差异化调控肝再生的“蓝斑—中缝”神经环路机制
    • 批准号:
      82371517
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      杨立群
    • 依托单位:
    新生儿坏死性小肠结肠炎中去泛素化酶USP15调控ILC3分化损伤肠道粘膜屏障的致病机制研究
    • 批准号:
      82371711
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      吕志宝
    • 依托单位: